Xiaohui Zhan

Prof. Dr. Xiaohui Zhan

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
XZXiaohui Zhan
Xiaohui Zhan
JCJun Cheng
Jun Cheng
ZHZhi Huang
Zhi Huang
ZHZhi Han
Zhi Han
BHBryan Helm
Bryan Helm
KHKun Huang
Kun Huang
Tumors are heterogeneous tissues with different types of cells such as cancer cells, fibroblasts, and lymphocytes. Although the morphological features of tumors are critical for cancer diagnosis and prognosis, the underlying molecular events and genes for tumor morphology are far from being clear. With the advancement in computational pathology and accumulation of large amount of cancer samples with matched molecular and histopathology data, researchers can carry out integrative analysis to investigate this issue. In this study, we systematically examine the relationships between morphological features and various molecular data in breast cancers. Specifically, we identified 73 breast cancer patients from the TCGA and CPTAC projects matched whole slide images, RNA-seq, and proteomic data. By calculating 100 different morphological features and correlating them with the transcriptomic and proteomic data, we inferred four major biological processes associated with various interpretable morphological features. These processes include metabolism, cell cycle, immune response, and extracellular matrix development, which are all hallmarks of cancers and the associated morphological features are related to area, density, and shapes of epithelial cells, fibroblasts, and lymphocytes. In addition, protein specific biological processes were inferred solely from proteomic data, suggesting the importance of proteomic data in obtaining a holistic understanding of the molecular basis for tumor tissue morphology. Furthermore, survival analysis yielded specific morphological features related to patient prognosis, which have a strong association with important molecular events based on our analysis. Overall, our study demonstrated the power for integrating multiple types of biological data for cancer samples in generating new hypothesis as well as identifying potential biomarkers predicting patient outcome. Future work includes causal analysis to identify key regulators for cancer tissue development and validating the findings using more independent data sets. Graphical Abstract Highlights Consistent correlation patterns between image-protein and image-mRNA at genome level. Four major biological processes associated with cellular and tissue morphology. Proteomic data reveal protein-specific biology processes associated with morphology. Morphological features can predict survival with relevant molecular events.

17 July 2021 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
ZLZixiao Lu
Zixiao Lu
XZXiaohui Zhan
Xiaohui Zhan
YWYi Wu
Yi Wu
JCJun Cheng
Jun Cheng
WSWei Shao
Wei Shao
KHKun Huang
Kun Huang
Epithelial and stromal tissues are components of the tumor microenvironment and play a major role in tumor initiation and progression. Distinguishing stroma from epithelial tissues is critically important for spatial characterization of the tumor microenvironment. Here, we propose BrcaSeg, an image analysis pipeline based on a convolutional neural network (CNN) model to classify epithelial and stromal regions in whole-slide hematoxylin and eosin (H&E) stained histopathological images. The CNN model is trained using well-annotated breast cancer tissue microarrays and validated with images from The Cancer Genome Atlas (TCGA) Program. BrcaSeg achieves a classification accuracy of 91.02%, which outperforms other state-of-the-art methods. Using this model, we generate pixel-level epithelial/stromal tissue maps for 1000 TCGA breast cancer slide images that are paired with gene expression data. We subsequently estimate the epithelial and stromal ratios and perform correlation analysis to model the relationship between gene expression and tissue ratios. Gene Ontology (GO) enrichment analyses of genes that are highly correlated with tissue ratios suggest that the same tissue is associated with similar biological processes in different breast cancer subtypes, whereas each subtype also has its own idiosyncratic biological processes governing the development of these tissues. Taken all together, our approach can lead to new insights in exploring relationships between image-based phenotypes and their underlying genomic events and biological processes for all types of solid tumors. BrcaSeg can be accessed at https://github.com/Serian1992/ImgBio.

29 July 2014 in Endocrine
Verified
Journal Article
Closed access
PDF file
MZMin Zhang
Min Zhang
JWJie Wang
Jie Wang
JJJingjing Jiang
Jingjing Jiang
XZXiaohui Zhan
Xiaohui Zhan
YLYan Ling
Yan Ling
BHBian Hua
Bian Hua

22 February 2024 in Signal, Image and Video Processing
Verified
Journal Article
Closed access
PDF file
JLJunjie Li
Junjie Li
KYKaixiang Yan
Kaixiang Yan
YYYu Yu
Yu Yu
XZXiaohui Zhan
Xiaohui Zhan
LLLingyu Li
Lingyu Li

1 December 2017 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
XZXiaohui Zhan
Xiaohui Zhan
QYQiangying Yi
Qiangying Yi
SCShuang Cai
Shuang Cai
XZxiaoxi Zhou
xiaoxi Zhou
SMShaohua Ma
Shaohua Ma
YWYao Wu
Yao Wu

30 August 2019 in Genes
Verified
Journal Article
Open access
PDF file
BHBryan Helm
Bryan Helm
XZXiaohui Zhan
Xiaohui Zhan
PPPankita H. Pandya
Pankita H. Pandya
MMMary E. Murray
Mary E. Murray
Karen E. PollokKaren E. Pollok
Karen E. Pollok
KHKun Huang
Kun Huang
Rhabdomyosarcoma is subclassified by the presence or absence of a recurrent chromosome translocation that fuses the FOXO1 and PAX3 or PAX7 genes. The fusion protein (FOXO1-PAX3/7) retains both binding domains and becomes a novel and potent transcriptional regulator in rhabdomyosarcoma subtypes. Many studies have characterized and integrated genomic, transcriptomic, and epigenomic differences among rhabdomyosarcoma subtypes that contain the FOXO1-PAX3/7 gene fusion and those that do not; however, few investigations have investigated how gene co-expression networks are altered by FOXO1-PAX3/7. Although transcriptional data offer insight into one level of functional regulation, gene co-expression networks have the potential to identify biological interactions and pathways that underpin oncogenesis and tumorigenicity. Thus, we examined gene co-expression networks for rhabdomyosarcoma that were FOXO1-PAX3 positive, FOXO1-PAX7 positive, or fusion negative. Gene co-expression networks were mined using local maximum Quasi-Clique Merger (lmQCM) and analyzed for co-expression differences among rhabdomyosarcoma subtypes. This analysis observed 41 co-expression modules that were shared between fusion negative and positive samples, of which 17/41 showed significant up- or down-regulation in respect to fusion status. Fusion positive and negative rhabdomyosarcoma showed differing modularity of co-expression networks with fusion negative (n = 109) having significantly more individual modules than fusion positive (n = 53). Subsequent analysis of gene co-expression networks for PAX3 and PAX7 type fusions observed 17/53 were differentially expressed between the two subtypes. Gene list enrichment analysis found that gene ontology terms were poorly matched with biological processes and molecular function for most co-expression modules identified in this study; however, co-expressed modules were frequently localized to cytobands on chromosomes 8 and 11. Overall, we observed substantial restructuring of co-expression networks relative to fusion status and fusion type in rhabdomyosarcoma and identified previously overlooked genes and pathways that may be targeted in this pernicious disease.